Traynor Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.8M | Buy |
|
|||||
|
2025
Q1 | $17.7M | Buy |
|
|||||
|
2024
Q4 | $17.7M | Buy |
|
|||||
|
2024
Q3 | $23.5M | Buy |
|
|||||
|
2024
Q2 | $21.4M | Buy |
|
|||||
|
2024
Q1 | $19M | Buy |
|
|||||
|
2023
Q4 | $16.6M | Buy |
|
|||||
|
2023
Q3 | $15M | Buy |
|
|||||
|
2023
Q2 | $12.6M | Buy |
|
|||||
|
2023
Q1 | $13.9M | Buy |
|
|||||
|
2022
Q4 | $11.4M | Sell |
|
|||||
|
2022
Q3 | $12.5M | Buy |
|
|||||
|
2022
Q2 | $10.6M | Buy |
|
|||||
|
2022
Q1 | $12.5M | Buy |
|
|||||
|
2021
Q4 | $10.9M | Buy |
|
|||||
|
2021
Q3 | $9.07M | Buy |
|
|||||
|
2021
Q2 | $7.93M | Buy |
|
|||||
|
2021
Q1 | $5.98M | Buy |
|
|||||
|
2020
Q4 | $5.88M | Buy |
|
|||||
|
2020
Q3 | $5.92M | Buy |
|
|||||
|
2020
Q2 | $5.94M | Buy |
|
|||||
|
2020
Q1 | $3.03M | Buy |
|
|||||
|
2019
Q4 | $1.1M | Sell |
|
|||||
|
2019
Q3 | $817K | Sell |
|
|||||
|
2019
Q2 | $966K | Buy |
|
|||||
|
2019
Q1 | $1.23M | Buy |
|
|||||
|
2018
Q4 | $602K | Buy |
|
|||||
|
2018
Q3 | $648K | Sell |
|
|||||
|
2018
Q2 | $572K | Buy |
|
|||||
|
2018
Q1 | $511K | Sell |
|
|||||
|
2017
Q4 | $575K | Buy |
|
|||||
|
2017
Q3 | $661K | Sell |
|
|||||
|
2017
Q2 | $833K | Sell |
|
|||||
|
2017
Q1 | $671K | Sell |
|
|||||
|
2016
Q4 | $597K | Sell |
|
|||||
|
2016
Q3 | $804K | Sell |
|
|||||
|
2016
Q2 | $823K | Sell |
|
|||||
|
2016
Q1 | $913K | Sell |
|
|||||
|
2015
Q4 | $1.54M | Buy |
|
|||||
|
2015
Q3 | $1.26M | Buy |
|
|||||
|
2015
Q2 | $1.37M | Buy |
|
|||||
|
2015
Q1 | $1.19M | Buy |
|
|||||
|
2014
Q4 | $959K | Buy |
|